USD
$0.00
(0.00%
)At Close (As of Sep 8, 2025)
$5.73M
Market Cap
-
P/E Ratio
-7.13
EPS
$7.50
52 Week High
$0.65
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$649K |
Total Revenue | $0 |
Cost Of Revenue | $649K |
Costof Goods And Services Sold | $649K |
Operating Income | -$14M |
Selling General And Administrative | $7.1M |
Research And Development | $7.2M |
Operating Expenses | $14M |
Investment Income Net | - |
Net Interest Income | $423K |
Interest Income | $423K |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $649K |
Income Before Tax | -$14M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$14M |
Comprehensive Income Net Of Tax | - |
Ebit | -$14M |
Ebitda | -$13M |
Net Income | -$14M |
Field | Value (USD) |
---|---|
Total Assets | $16M |
Total Current Assets | $7.4M |
Cash And Cash Equivalents At Carrying Value | $6.9M |
Cash And Short Term Investments | $6.9M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $8.7M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $7.3M |
Intangible Assets Excluding Goodwill | $7.3M |
Goodwill | $1.3M |
Investments | - |
Long Term Investments | - |
Short Term Investments | $6.9B |
Other Current Assets | $446K |
Other Non Current Assets | - |
Total Liabilities | $1.3M |
Total Current Liabilities | $1.1M |
Current Accounts Payable | $1.1M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | - |
Total Non Current Liabilities | $162K |
Capital Lease Obligations | $0 |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | - |
Other Current Liabilities | $1.1M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $15M |
Treasury Stock | - |
Retained Earnings | -$50B |
Common Stock | $139 |
Common Stock Shares Outstanding | $1.1M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$14K |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $649 |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | - |
Cashflow From Financing | $4.5B |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $360M |
Dividend Payout Common Stock | $360M |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $0 |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$14K |
Field | Value (USD) |
---|---|
Gross Profit | -$649K |
Total Revenue | $0 |
Cost Of Revenue | $649K |
Costof Goods And Services Sold | $649K |
Operating Income | -$14M |
Selling General And Administrative | $7.1M |
Research And Development | $7.2M |
Operating Expenses | $14M |
Investment Income Net | - |
Net Interest Income | $423K |
Interest Income | $423K |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $649K |
Income Before Tax | -$14M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$14M |
Comprehensive Income Net Of Tax | - |
Ebit | -$14M |
Ebitda | -$13M |
Net Income | -$14M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Pasithea Therapeutics Corp. The company is headquartered in Miami Beach, Florida.